4//SEC Filing
Gruskin Daniel 4
Accession 0001209191-22-015804
CIK 0001664106other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:07 PM ET
Size
5.7 KB
Accession
0001209191-22-015804
Insider Transaction Report
Form 4
Gruskin Daniel
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-03-01+140,000→ 140,000 totalExercise: $0.70Exp: 2032-03-01→ Common Stock (140,000 underlying)
Footnotes (2)
- [F1]The options were granted by LogicBio Therapeutics, Inc. (the "Company") pursuant to its 2018 Equity Incentive Plan.
- [F2]The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Company on each vesting date.
Documents
Issuer
LogicBio Therapeutics, Inc.
CIK 0001664106
Entity typeother
Related Parties
1- filerCIK 0001863053
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 6:07 PM ET
- Size
- 5.7 KB